- Home
- BLUE vs ANEB Comparison
BLUE vs ANEB Comparison
Compare BLUE & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLUE
- ANEB
- Stock Information
- Founded
- BLUE 1992
- ANEB 2020
- Country
- BLUE United States
- ANEB United States
- Employees
- BLUE N/A
- ANEB N/A
- Industry
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- BLUE Health Care
- ANEB Health Care
- Exchange
- BLUE Nasdaq
- ANEB Nasdaq
- Market Cap
- BLUE 36.9M
- ANEB 36.7M
- IPO Year
- BLUE 2013
- ANEB 2021
- Fundamental
- Price
- BLUE $4.09
- ANEB $0.97
- Analyst Decision
- BLUE Hold
- ANEB Buy
- Analyst Count
- BLUE 7
- ANEB 1
- Target Price
- BLUE $44.60
- ANEB $8.00
- AVG Volume (30 Days)
- BLUE 524.5K
- ANEB 18.9K
- Earning Date
- BLUE 05-08-2025
- ANEB 05-14-2025
- Dividend Yield
- BLUE N/A
- ANEB N/A
- EPS Growth
- BLUE N/A
- ANEB N/A
- EPS
- BLUE N/A
- ANEB N/A
- Revenue
- BLUE $83,807,000.00
- ANEB N/A
- Revenue This Year
- BLUE $218.58
- ANEB N/A
- Revenue Next Year
- BLUE N/A
- ANEB N/A
- P/E Ratio
- BLUE N/A
- ANEB N/A
- Revenue Growth
- BLUE 184.12
- ANEB N/A
- 52 Week Low
- BLUE $3.56
- ANEB $0.80
- 52 Week High
- BLUE $28.60
- ANEB $3.20
- Technical
- Relative Strength Index (RSI)
- BLUE 43.15
- ANEB 37.94
- Support Level
- BLUE $3.83
- ANEB $0.95
- Resistance Level
- BLUE $5.15
- ANEB $1.10
- Average True Range (ATR)
- BLUE 0.40
- ANEB 0.11
- MACD
- BLUE -0.05
- ANEB -0.00
- Stochastic Oscillator
- BLUE 18.44
- ANEB 28.00
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.